These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 4075945

  • 1. Time as a risk factor in diabetic nephropathy.
    Nyberg G, Larsson O, Attman PO, Granérus G, Nordén G.
    Diabetes Care; 1985; 8(6):590-3. PubMed ID: 4075945
    [Abstract] [Full Text] [Related]

  • 2. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R, Spinas GA.
    Praxis (Bern 1994); 1995 Oct 31; 84(44):1265-71. PubMed ID: 7491450
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy.
    Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR.
    Diabetologia; 1981 Apr 31; 20(4):457-61. PubMed ID: 7016639
    [Abstract] [Full Text] [Related]

  • 4. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine.
    Sampson MJ, Drury PL.
    Diabetes Care; 1992 May 31; 15(5):609-12. PubMed ID: 1516478
    [Abstract] [Full Text] [Related]

  • 5. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.
    Mathiesen ER, Feldt-Rasmussen B, Hommel E, Deckert T, Parving HH.
    Diabetes Care; 1997 Mar 31; 20(3):286-9. PubMed ID: 9051373
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T, Ahbap E.
    Eur Rev Med Pharmacol Sci; 2012 Jul 31; 16(7):878-83. PubMed ID: 22953635
    [Abstract] [Full Text] [Related]

  • 7. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes.
    Hasslacher C, Stech W, Wahl P, Ritz E.
    Diabetologia; 1985 Jan 31; 28(1):6-11. PubMed ID: 3979689
    [Abstract] [Full Text] [Related]

  • 8. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P, Zuccalà A, Sturani A.
    Postgrad Med J; 1988 Jan 31; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [Abstract] [Full Text] [Related]

  • 9. Premature cell ageing and evolution of diabetic nephropathy.
    Morocutti A, Earle KA, Rodemann HP, Viberti GC.
    Diabetologia; 1997 Feb 31; 40(2):244-6. PubMed ID: 9049488
    [Abstract] [Full Text] [Related]

  • 10. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.
    Diabetes; 1997 Mar 31; 46(3):481-7. PubMed ID: 9032106
    [Abstract] [Full Text] [Related]

  • 11. Cholesterol: a renal risk factor in diabetic nephropathy?
    Mulec H, Johnsen SA, Wiklund O, Björck S.
    Am J Kidney Dis; 1993 Jul 31; 22(1):196-201. PubMed ID: 8322783
    [Abstract] [Full Text] [Related]

  • 12. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetes; 1993 May 31; 42(5):715-9. PubMed ID: 8482428
    [Abstract] [Full Text] [Related]

  • 13. Smoking and diabetic nephropathy.
    Nordén G, Nyberg G.
    Acta Med Scand; 1984 May 31; 215(3):257-61. PubMed ID: 6731038
    [Abstract] [Full Text] [Related]

  • 14. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P, Tarnow L, Oestergaard PB, Parving HH.
    Kidney Int Suppl; 2000 Apr 31; 75():S56-61. PubMed ID: 10828763
    [Abstract] [Full Text] [Related]

  • 15. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.
    Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O.
    Nephrol Dial Transplant; 2002 Aug 31; 17(8):1408-12. PubMed ID: 12147787
    [Abstract] [Full Text] [Related]

  • 16. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM.
    Sundkvist G, Lilja B.
    Diabetes Care; 1993 May 31; 16(5):773-9. PubMed ID: 8495619
    [Abstract] [Full Text] [Related]

  • 17. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
    Mogensen CE.
    Diabetes; 1990 Jul 31; 39(7):761-7. PubMed ID: 2191882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM.
    Mogensen CE, Hansen KW, Pedersen MM, Christensen CK.
    Diabetes Care; 1991 Nov 31; 14 Suppl 4():13-26. PubMed ID: 1748053
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.